Synthesis, ADMT prediction, and


Journal

RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657

Informations de publication

Date de publication:
22 Jun 2023
Historique:
received: 18 03 2023
accepted: 17 06 2023
medline: 28 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

In this work, a new series of quinoline-quinazolinone-thioacetamide derivatives 9a-p were designed using a combination of effective pharmacophores of the potent α-glucosidase inhibitors. These compounds were synthesized by simple chemical reactions and evaluated for their anti-α-glucosidase activity. Among the tested compounds, compounds 9a, 9f, 9g, 9j, 9k, and 9m demonstrated significant inhibition effects in comparison to the positive control acarbose. Particularly, compound 9g with inhibitory activity around 83-fold more than acarbose exhibited the best anti-α-glucosidase activity. Compound 9g showed a competitive type of inhibition in the kinetic study, and the molecular simulation studies demonstrated that this compound with a favorable binding energy occupied the active site of α-glucosidase. Furthermore,

Identifiants

pubmed: 37377867
doi: 10.1039/d3ra01790g
pii: d3ra01790g
pmc: PMC10291282
doi:

Types de publication

Journal Article

Langues

eng

Pagination

19243-19256

Informations de copyright

This journal is © The Royal Society of Chemistry.

Déclaration de conflit d'intérêts

All the authors declare that they have no conflict of interest.

Références

Bioorg Chem. 2018 Oct;80:288-295
pubmed: 29980114
Sci Rep. 2022 Aug 18;12(1):14019
pubmed: 35982225
ChemMedChem. 2017 Jun 7;12(11):819-829
pubmed: 28498640
Cancer Res. 1986 Oct;46(10):5215-22
pubmed: 3093061
Proc Natl Acad Sci U S A. 1988 Dec;85(23):9229-33
pubmed: 3264071
Steroids. 2018 Dec;140:131-143
pubmed: 30315840
Am J Ther. 2011 Mar-Apr;18(2):117-52
pubmed: 19834322
Eur J Med Chem. 2019 Aug 15;176:343-377
pubmed: 31112894
Bioorg Med Chem. 2017 Feb 15;25(4):1303-1308
pubmed: 28110817
Bioorg Med Chem. 2021 Feb 15;32:115973
pubmed: 33444846
J Agric Food Chem. 2010 Sep 22;58(18):9988-93
pubmed: 20734984
Bioorg Chem. 2018 Aug;78:195-200
pubmed: 29587132
Bioorg Med Chem. 2019 Sep 15;27(18):4081-4088
pubmed: 31378594
Nat Prod Rep. 2010 Oct;27(10):1431-68
pubmed: 20714463
Nat Commun. 2017 Oct 24;8(1):1111
pubmed: 29061980
Bioorg Chem. 2022 Oct;127:105996
pubmed: 35878449
Mini Rev Med Chem. 2010 Aug;10(9):773-93
pubmed: 20105118

Auteurs

Sajedeh Safapoor (S)

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran momahdavi@tums.ac.ir.

Mohammad Halimi (M)

Department of Biology, Islamic Azad University Babol Branch Babol Iran.

Minoo Khalili Ghomi (MK)

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran momahdavi@tums.ac.ir.

Milad Noori (M)

Pharmaceutical and Heterocyclic Chemistry Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran.

Navid Dastyafteh (N)

Pharmaceutical and Heterocyclic Chemistry Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran.

Shahrzad Javanshir (S)

Pharmaceutical and Heterocyclic Chemistry Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran.

Samanesadat Hosseini (S)

Shahid Beheshti University of Medical Sciences Tehran Iran.

Somayeh Mojtabavi (S)

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences Tehran Iran.

Mohammad Ali Faramarzi (MA)

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences Tehran Iran.

Ensieh Nasli-Esfahani (E)

Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran.

Bagher Larijani (B)

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran momahdavi@tums.ac.ir.

Azadeh Fakhrioliaei (A)

Faculty of Pharmacy, Islamic Azad University Pharmaceutical Sciences Branch Tehran Iran.

Mohammad G Dekamin (MG)

Pharmaceutical and Heterocyclic Chemistry Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran.

Maryam Mohammadi-Khanaposhtani (M)

Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences Babol Iran maryammoha@gmail.com.

Mohammad Mahdavi (M)

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran momahdavi@tums.ac.ir.

Classifications MeSH